Streetbeat News

Earnings

BEN

Franklin Resources (NYSE:BEN) reported Q1 adjusted earnings per share (EPS) of $0.65, surpassing the consensus estimate of $0.57 by 14.04%. Year-over-year, this represents a 27.45% increase from $0.51 EPS. Quarterly sales reached $1.99 billion, exceeding estimates of $1.52 billion by 31.25% and marking a 1.22% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 1:31 pm

NWFL

Norwood Financial reported a significant decrease in its Q4 earnings per share (EPS), with a drop from $0.88 in the previous year to $0.04 this year.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 1:27 pm

PHG

Koninklijke Philips' stock trades lower following the release of their Q4 financial results.

Portfolio Pulse from Luke J Jacobi

January 29, 2024 | 1:23 pm

DTCK

Davis Commodities Limited, celebrating its 25th anniversary in 2024, has successfully listed on Nasdaq under the symbol 'DTCK' and is undergoing strategic consolidation to streamline operations. The company completed an IPO on September 21, 2023, raising approximately $5 million. It is now focusing on growth opportunities in the Asian sugar, oil, and rice markets, which are projected to grow significantly in 2024 according to a Frost & Sullivan Limited report.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 1:17 pm

SOFI

SoFi Technologies Inc (NASDAQ:SOFI) stock surged after reporting Q4 2023 earnings that exceeded expectations. Adjusted revenue was up 34% Y/Y to $594.25 million, surpassing the consensus of $571.70 million. Adjusted EPS was $0.02, beating the expected $0.00. The company saw a significant increase in members and products, with a 44% Y/Y growth in members and a 41% Y/Y increase in products. Adjusted EBITDA jumped 159% Y/Y to $181 million. SoFi provided a positive outlook for Q1 and full-year 2024, with expected growth in various segments and an adjusted EBITDA margin of approximately 30% by year-end. The company also anticipates a 20%-25% CAGR from 2023 through 2026.

Portfolio Pulse from Anusuya Lahiri

January 29, 2024 | 1:17 pm

ARQT

Arcutis Biotherapeutics announced that the Journal of American Academy of Dermatology has published results from its Phase 3 STRATUM trial for ZORYVE Foam, 0.3%. The trial results indicate that the novel steroid-free topical foam is effective in controlling seborrheic dermatitis. ZORYVE has been approved for the treatment of seborrheic dermatitis in individuals aged 9 years and older.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 1:15 pm

BSVN

Bank7 (NASDAQ:BSVN) reported Q4 earnings with an EPS of $0.12, beating estimates by 33.33% against the expected $0.09. Revenue increased by $6.95 million compared to the same period last year. Despite missing EPS last quarter, the share price increased by 0.58% the following day. Historical earnings data shows mixed performance over the past four quarters.

Portfolio Pulse from Benzinga Insights

January 29, 2024 | 1:10 pm

BSVN

Bank7 (NASDAQ:BSVN) reported Q4 earnings of $0.12 per share, surpassing the $0.09 estimate, and sales of $28.07M, exceeding the $21.60M estimate. However, earnings per share decreased by 86.81% compared to last year, while sales increased by 32.93% from the same period.

Portfolio Pulse from totan@benzinga.com

January 29, 2024 | 1:07 pm

DX

Dynex Capital (NYSE:DX) reported Q4 losses of $(0.24) per share, missing the $(0.20) estimate by 20%, and a 900% decrease from $0.03 per share last year. Sales were $(2.28M), beating the $(5.62M) estimate by 59.48%, but down 136.68% from $6.21M last year.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 1:02 pm

BLDR

Builders FirstSource (NYSE:BLDR) has been rated by 10 analysts in the last three months, with an average 12-month price target of $170.7, up from $165.71. Ratings range from 'Outperform' to 'Neutral', with price targets varying from $143.00 to $220.00. The company's financial performance shows a negative revenue trend with a -21.3% growth, a net margin of 9.96%, ROE of 10.12%, and an impressive ROA of 4.21%. Its debt-to-equity ratio is 0.85, below industry average.

Portfolio Pulse from Benzinga Insights

January 29, 2024 | 1:01 pm